|
WO2021011925A1
|
|
Treatment of urothelial and kidney cancers by use of endothelin b receptor antagonists
|
|
US2020289495A1
|
|
Methods of inhibiting endothelin b receptor expressing tumor metastases
|
|
US2020268829A1
|
|
Methods and compositions for inhibiting metastases of an endothelin b receptor expressing cancer
|
|
WO2019191721A1
|
|
Etbr antagonist compounds, compositions, and uses
|
|
CA3087009A1
|
|
Deuterated compounds, compositions, and methods for treating cancers associated with etbr activation
|
|
AU2016302254A1
|
|
Compositions and methods for treating cancers associated with ETBR activation
|
